UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter

Cancer research (Chicago, Ill.), 2000-11, Vol.60 (22), p.6526-6530

2000

Link zum Volltext

Verfügbarkeit prüfen

In vivo sodium iodide symporter gene therapy of prostate cancer

Gene therapy, 2001-10, Vol.8 (20), p.1524-1531

2001

Link zum Volltext

Verfügbarkeit prüfen

The sodium iodide symporter: its pathophysiological and therapeutic implications

Clinical endocrinology (Oxford), 2002-11, Vol.57 (5), p.559-574

2002

Link zum Volltext

Verfügbarkeit prüfen

Retinoic Acid-Induced Stimulation of Sodium Iodide Symporter Expression and Cytotoxicity of Radioiodine in Prostate Cancer Cells

Endocrinology (Philadelphia), 2003-08, Vol.144 (8), p.3423-3432

2003

Link zum Volltext

Verfügbarkeit prüfen

Dexamethasone Enhances the Cytotoxic Effect of Radioiodine Therapy in Prostate Cancer Cells Expressing the Sodium Iodide Symporter

The journal of clinical endocrinology and metabolism, 2004-03, Vol.89 (3), p.1108-1116

2004

Link zum Volltext

Verfügbarkeit prüfen

Expression of Thyroid-Related Genes in Human Thymus

Thyroid (New York, N.Y.), 1999-02, Vol.9 (2), p.133-141

1999

Link zum Volltext

Verfügbarkeit prüfen

Salvage PRRT with 177 Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

BMC cancer, 2019-08, Vol.19 (1), p.788

2019

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines

Cancer research (Chicago, Ill.), 1999-05, Vol.59 (9), p.2136-2141

1999

Link zum Volltext

Verfügbarkeit prüfen

Radioiodine Therapy and Graves' Ophthalmopathy

Thyroid (New York, N.Y.), 1998-12, Vol.8 (12), p.1193-1193

1998

Link zum Volltext

Verfügbarkeit prüfen

Selenium-induced thyroid dysfunction

Postgraduate medical journal, 1997-02, Vol.73 (856), p.103-104

1997

Link zum Volltext

Verfügbarkeit prüfen

Dermatitis Herpetiformis Cured by Hormone Replacement for Panhypopituitarism

Endocrine Journal, 1997, Vol.44(3), pp.437-440

1997

Link zum Volltext

Verfügbarkeit prüfen

Infectious thyroiditis as initial manifestation of embolizing endocarditis of the aortic valve

Deutsche medizinische Wochenschrift, 1996-03, Vol.121 (12), p.369

1996

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia

Endocrine-related cancer, 2019-03, Vol.26 (3), p.293-301

2019

Link zum Volltext

Verfügbarkeit prüfen

Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology

The journal of clinical endocrinology and metabolism, 2020-06, Vol.105 (6), p.e2239-e2246

2020

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT

Cancer imaging, 2018-09, Vol.18 (1), p.34-34, Article 34

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography

Molecular Imaging, 2014-06, Vol.13 (4), p.1-10

2014

Link zum Volltext

Verfügbarkeit prüfen

Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2021-10, Vol.48 (11), p.3571-3581

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of (68)Ga-DOTATATE PET/CT on the surgical management of primary neuroendocrine tumors of the pancreas or ileum

Annals of surgical oncology, 2015-01, Vol.22 (1), p.164-171

2015

Link zum Volltext

Verfügbarkeit prüfen

Lessons learned: the first consecutive 1000 patients of the CCCMunich LMU Molecular Tumor Board

Journal of cancer research and clinical oncology, 2023-05, Vol.149 (5), p.1905

2023

Link zum Volltext

Verfügbarkeit prüfen

The added diagnostic value of complementary gadoxetic acid-enhanced MRI to 18 F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma

Cancer imaging, 2019-11, Vol.19 (1), p.73

2019

Link zum Volltext

Verfügbarkeit prüfen

The added value of 68 Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin

European radiology, 2017-04, Vol.27 (4), p.1676

2017

Link zum Volltext

Verfügbarkeit prüfen

The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer

European journal of nuclear medicine and molecular imaging, 2008-07, Vol.35 (7), p.1272-1281

2008

Link zum Volltext

Verfügbarkeit prüfen

Application of 188Rhenium as an Alternative Radionuclide for Treatment of Prostate Cancer after Tumor-Specific Sodium Iodide Symporter Gene Expression

The journal of clinical endocrinology and metabolism, 2007-11, Vol.92 (11), p.4451-4458

2007

Link zum Volltext

Verfügbarkeit prüfen

Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (22), p.7840-7844

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)

Publikationsform

Artikel
(24)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Female
(13)
Middle Aged
(11)
Adult
(10)
Aged
(9)
Endocrinology & Metabolism
(8)
Biological And Medical Sciences
(7)
Prostatic Neoplasms - Metabolism
(7)
Symporters - Genetics
(7)
Iodine Radioisotopes - Therapeutic Use
(6)
Medical Sciences
(6)
Oncology
(6)
Prostatic Neoplasms - Radiotherapy
(6)
Tumors
(6)
Retrospective Studies
(5)
Symporters - Metabolism
(5)
Adenocarcinoma - Metabolism
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter

In vivo sodium iodide symporter gene therapy of prostate cancer

The sodium iodide symporter: its pathophysiological and therapeutic implications

Retinoic Acid-Induced Stimulation of Sodium Iodide Symporter Expression and Cytotoxicity of Radioiodine in Prostate Cancer Cells

Dexamethasone Enhances the Cytotoxic Effect of Radioiodine Therapy in Prostate Cancer Cells Expressing the Sodium Iodide Symporter

Expression of Thyroid-Related Genes in Human Thymus

Salvage PRRT with 177 Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines

Radioiodine Therapy and Graves' Ophthalmopathy

Selenium-induced thyroid dysfunction

Dermatitis Herpetiformis Cured by Hormone Replacement for Panhypopituitarism

Infectious thyroiditis as initial manifestation of embolizing endocarditis of the aortic valve

Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia

Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT

Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography

Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours

Impact of (68)Ga-DOTATATE PET/CT on the surgical management of primary neuroendocrine tumors of the pancreas or ileum

Lessons learned: the first consecutive 1000 patients of the CCCMunich LMU Molecular Tumor Board

The added diagnostic value of complementary gadoxetic acid-enhanced MRI to 18 F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma

The added value of 68 Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin

The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer

Application of 188Rhenium as an Alternative Radionuclide for Treatment of Prostate Cancer after Tumor-Specific Sodium Iodide Symporter Gene Expression

Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer

Aktive Filter

Suchergebnisse filtern